Ulobetasol
Systematic (IUPAC) name | |
---|---|
(6α,11β,16β)-21-chloro-6,9-difluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione | |
Clinical data | |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a601060 |
Identifiers | |
98651-66-2 | |
D07AC21 | |
PubChem | CID 5311167 |
ChemSpider | 4470691 |
UNII | 9P6159HM7T |
KEGG | D08660 |
ChEMBL | CHEMBL1201360 |
Synonyms | (6S,8S,9S,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one |
Chemical data | |
Formula | C22H27ClF2O4 |
428.897 | |
SMILES
| |
| |
(what is this?) (verify) |
Ulobetasol (INN) or halobetasol (USAN) is a corticosteroid used to treat psoriasis. It is a group I corticosteroid under the US classification, the most potent class of such drugs. Halobetasol propionate is usually supplied as a 0.05% topical cream.
External links
- halobetasol at the US National Library of Medicine Medical Subject Headings (MeSH)
|